A team of researchers has now engineered a virus nanoparticle vaccine against Bacillus anthracis and Yersinia pestis, tier 1 agents that pose serious threats to national security of the United States.
Oct 16, 2018
0
0
(HealthDay)—Final guidance has been issued by the U.S. Food and Drug Administration to assist in the development of drugs for the prevention of inhalational anthrax for individuals who may have been exposed but who have ...
Jun 1, 2018
0
1
(HealthDay)—Two cases of cutaneous anthrax which started on the right forearm and progressed are described in a case report published online Dec. 12 in the International Journal of Dermatology.
Dec 20, 2017
0
5
(HealthDay)—During and after the First World War, there was an increase in anthrax cases associated with use of new shaving brushes, which were made of imported horsehair, according to research published in the May issue ...
Apr 17, 2017
0
0
Researchers from Harvard Medical School have discovered that the body's immune system initially detects the presence of anthrax spores by recognizing RNA molecules that coat the spores' surface. But this prompts an unfavorable ...
Apr 11, 2017
0
2
A new study by the Translational Genomics Research Institute (TGen) and Northern Arizona University (NAU) used deep DNA sequencing methods to generate the anthrax genome sequence from the victims of the 1979 anthrax outbreak ...
Sep 7, 2016
0
0
A 12-year-old boy has died in an anthrax outbreak in remote far northern Russia while dozens have been hospitalised on suspicion of infection, the region's governor said Monday.
Aug 1, 2016
0
21
Vaccination with the anthrax capsule—a naturally occurring component of the bacterium that causes the disease—completely protected monkeys from lethal anthrax infection, according to a study published online this week ...
Jun 27, 2016
0
3
Federal health officials have approved a new injectable drug to treat patients who have been exposed to the deadly toxin anthrax.
Mar 21, 2016
0
0
(HealthDay)—U.S. Food and Drug Administration approval for the BioThrax anthrax vaccine has been expanded to include adults aged 18 to 65 with known or suspected exposure, the agency said in a media release.
Nov 24, 2015
0
2
